Dr Tara Bowen obtained her PhD in Biosciences from the University of Birmingham in 2023. As part of a collaboration between Prof Mark Viant’s Metabolomics and System Toxicology laboratory and AstraZeneca, Tara’s research focused on developing and implementing mass spectrometry-based metabolomics workflows as a strategy towards discovering predictive biomarkers of drug-induced cardiotoxicity.
Tara’s current focus at Medicines Discovery Catapult is on delivering mass spectrometry-based metabolomics and small molecule analysis to support diverse drug discovery projects.
